Episode Overview
Podcast: Becker Private Equity & Business Podcast
Host: Scott Becker
Episode Title: Hims & Hers Tanks on Friday 10-20-25
Date: October 20, 2025
In this episode, Scott Becker discusses the recent volatility in Hims & Hers Health, Inc.’s stock price. The conversation centers on the stock’s impressive run-up earlier in the week, followed by a significant downturn towards the end. Becker analyzes the factors influencing this shift, particularly focusing on analyst opinions and market sentiment.
Key Discussion Points & Insights
1. Stock Performance Recap
- Early Week Surge:
- Hims & Hers experienced a substantial one-day jump of 16% earlier in the week.
- "Hims or hers has been on a hell of a run. In fact, early this week it jumped 16% on one day." (Scott Becker, 00:11)
- Late Week Decline:
- The stock dropped approximately 13-15% over Thursday and Friday.
- "Last two days of the week it dropped about 15%, 13% or so or more on Friday and some on Thursday as well." (00:25)
- By Friday midday, the stock was down 13-14%.
2. Catalysts for the Downturn
- Analyst Sell Rating:
- A significant driver was an analyst from Bank of America issuing a "sell" rating.
- "That's basically due to a B of a analyst essentially saying that Hims and Hers is overpriced and has a number of concerns that aren't showing up as well in the financials as it should." (00:35)
- Market Reaction:
- The negative analyst note weighed heavily on the stock's performance for those days.
- "That's sort of the concept of somebody adding a sell rating to the Hims and Hers sort of stock. That's what's driving the decrease in value today." (00:48)
3. Contextualizing the Volatility
- Year-to-Date Performance:
- Despite the recent drop, Hims & Hers remains substantially up for the year—approximately 111%.
- "At the end of the day, Hims and hers still up about 11, 111% year to date. So nothing to worry about there in the big scheme of things." (00:57)
- Host’s Perspective:
- Becker clarifies he is not a shareholder but observes the company’s growth with interest.
- "I am not a direct investor in Hims and Hers. I do find it fascinating to see the growth that they've had and what they're doing." (01:08)
4. News & Momentum Drivers
- Positive News Mid-Week:
- The mid-week surge was attributed to news of a new offering related to menopause.
- "They popped on Wednesday on news of a new sort of either offering around menopause, but then got hurt badly on Thursday and Friday at the end of the day..." (01:17)
- Sustained Outperformance:
- Even accounting for the downturn, Becker notes the strong performance both year-to-date and over the last 52 weeks.
Memorable Quotes & Timestamps
- On rapid stock movements:
- "Hims or hers has been on a hell of a run. In fact, early this week it jumped 16% on one day." (Scott Becker, 00:11)
- On the cause of sell-off:
- "That's basically due to a B of a analyst essentially saying that Hims and Hers is overpriced and has a number of concerns that aren't showing up as well in the financials as it should." (00:35)
- On overall performance:
- "At the end of the day, Hims and hers still up about 11, 111% year to date. So nothing to worry about there in the big scheme of things." (00:57)
- Host’s disclosure:
- "I am not a direct investor in Hims and Hers. I do find it fascinating to see the growth that they've had and what they're doing." (01:08)
Important Timestamps
- 00:11: Stock’s strong mid-week rally
- 00:25: Description of Thursday and Friday losses
- 00:35: Analyst sell rating explanation
- 00:57: Context of overall yearly gain
- 01:17: Discussion of menopause-focused offering news
Summary & Takeaways
- Hims & Hers’ stock was highly volatile this week, surging on promising product news but quickly dropping following a bearish analyst report.
- Despite the volatility, the company is still showing impressive returns for the year.
- Scott Becker provides an impartial overview, noting the influence of analyst ratings and media on stock movements in the business and private equity landscape.
This episode provides a crisp, analytical look at short-term market reactions, the power of analyst influence, and the resilience of high-growth companies in the face of market headwinds.
